T. Sakamoto

发表

Construction of retroviral vectors to induce strong hepatoma cell‐specific expression of cytokine genes

S. Kuriyama, Z. Qi, G. Cao, 1996, Journal of gastroenterology and hepatology.

Tissue‐specific expression of HSV‐tk gene can induce efficient antitumor effect and protective immunity to wild‐type hepatocellular carcinoma

S. Kuriyama, K. Ikenaka, M. Kikukawa, 1997, International journal of cancer.

Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C.

A. Mitoro, K. Yamamoto, M. Yoshikawa, 1993, Internal medicine.

Chronic active Epstein-Barr virus infection in an adult.

H. Fukui, H. Kojima, M. Uemura, 1992, Internal medicine.

Autoimmunity during alpha-interferon therapy for chronic hepatitis C

H. Yoshiji, A. Mitoro, H. Fukui, 1993, Gastroenterologia Japonica.

Cytosine deaminase/5‐fluorocytosine gene therapy can induce efficient anti‐tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice

H. Yoshiji, S. Kuriyama, K. Ikenaka, 1999, International journal of cancer.

Bacterial cytosine deaminase suicide gene transduction renders hepatocellular carcinoma sensitive to the prodrug 5-fluorocytosine

S. Kuriyama, K. Ikenaka, C. Mullen, 1995 .

Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene

H. Yoshiji, S. Kuriyama, S. Nagao, 1999, Gene Therapy.

Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment

S. Kuriyama, K. Ikenaka, M. Kikukawa, 1998, Gene Therapy.

Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene.

S. Kuriyama, K. Ikenaka, T. Nakatani, 1996, Anticancer research.

Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma

S. Kuriyama, K. Ikenaka, T. Nakatani, 1995, Hepatology.

Gene therapy for the treatment of hepatoma by retroviral-mediated gene transfer of the herpes simplex virus thymidine kinase

S. Kuriyama, K. Ikenaka, T. Nakatani, 1993 .

Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer.

S. Kuriyama, Z. Qi, G. Cao, 1997, Gastroenterology.

Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan

H. Yoshiji, S. Kuriyama, M. Shima, 1995, Journal of Gastroenterology.

A case of early gastric malignant lymphoma diagnosed and completely resected by strip biopsy

H. Yoshiji, S. Kuriyama, Y. Konishi, 1995, Journal of Gastroenterology.

Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.

H. Yoshiji, S. Kuriyama, K. Ikenaka, 1998, Anticancer research.

Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma

S. Kuriyama, K. Ikenaka, T. Nakatani, 1995, Hepatology.